SEC
SRPT icon

Seven Eight Capital’s Sarepta Therapeutics SRPT Stock Holding History

Seven Eight Capital’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,404
Closed -$925K – 556
2024
Q3 		$925K Sell
7,404
-17,280
-70% -$2.39M 0.08% 425
2024
Q2 		$3.9M Buy
24,684
+16,405
+198% +$2.11M 0.41% 42
2024
Q1 		$1.07M Buy
8,279
+2,330
+39% +$285K 0.11% 284
2023
Q4 		$574K Buy
+5,949
New +$571K 0.07% 393
2023
Q1 		– Sell
-2,280
Closed -$295K – 600
2022
Q4 		$295K Buy
+2,280
New +$264K 0.08% 313
2020
Q4 		– Sell
-1,700
Closed -$239K – 614
2020
Q3 		$239K Buy
+1,700
New +$258K 0.05% 490
2020
Q1 		– Sell
-51,574
Closed -$6.66M – 688
2019
Q4 		$6.66M Sell
51,574
-1,100
-2% -$111K 0.35% 77
2019
Q3 		$3.97M Buy
+52,674
New +$6.22M 0.21% 136
2018
Q3 		– Sell
-50,854
Closed -$6.72M – 697
2018
Q2 		$6.72M Buy
+50,854
New +$4.8M 0.47% 69
2017
Q3 		– Sell
-18,614
Closed -$627K – 604
2017
Q2 		$627K Buy
+18,614
New +$606K 0.09% 282
2016
Q3 		– Sell
-25,302
Closed -$483K – 529
2016
Q2 		$483K Buy
+25,302
New +$469K 0.17% 195
2016
Q1 		– Sell
-3,700
Closed -$143K – 675
2015
Q4 		$143K Buy
3,700
+3,300
+825% +$107K 0.1% 295
2015
Q3 		$13K Buy
+400
New +$13.6K 0.01% 435

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Seven Eight Capital's SRPT Position: Q4 2024 in Review

Seven Eight Capital sold out of Sarepta Therapeutics (SRPT) in Q4 2024, closing a stake of 7,404 shares — an estimated $925K sold.

Seven Eight Capital first reported a position in SRPT in Q3 2015 and held it in 13 quarters. The position peaked at $6.72M in Q2 2018. 465 funds tracked by Wall St. Rank hold SRPT as of Q4 2024.

  • Seven Eight Capital reported no remaining Sarepta Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Seven Eight Capital sold 7,404 Sarepta Therapeutics shares in Q4 2024, an estimated $925K.
  • Seven Eight Capital first reported a position in Sarepta Therapeutics in Q3 2015 and held it in 13 quarters.
  • Seven Eight Capital's Sarepta Therapeutics position peaked at $6.72M in Q2 2018.
  • 465 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2024.

Based on Seven Eight Capital's 13F filing for Q4 2024.